• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Caelum Biosciences Inc.

Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet and who’s a pure gamble.

Steve Walker    February 8, 2019 February 8, 2019    No Comments on Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet and who’s a pure gamble.

The healthcare stock market’s recent success is largely dependent on the fact that, as the global population increases and more people need access to healthcare, companies in the space are prepared… Read more »

Corporate, Investment, Pharmaceuticals    AC Immune SA, Alexion Pharmaceuticals Inc., Aquestive Therapeutics Inc., Avalon GloboCare Inc., Caelum Biosciences Inc., Fortress Biotech Inc., Keith Kendall, Zynerba Pharmaceuticals Inc.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
  • Three healthcare stocks shine while two fizzle to cap the first month of 2019’s investor lottery. Who’s a rational bet...
  • IPOs are back in business; well, unless and until there’s another government shutdown.
  • And now for something completely different in biotech: Lab-grown, “clean” meat. If Bill Gates and Warren Buffett like the idea...well?...
    • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
    • Unknown Kentucky biotech Bexion tests new glioma med on first patients. Yes, it’s the same cancer Sen. McCain is fighting,...
    • Biotech IPOs rock in 2018. More are storming into the queue.
    • Apitope moves Graves’ disease candidate toward Phase 2; a primer on autoimmune disease “for people in a hurry.”
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress